If you've ever used an at-home genetic test, there is a chance your information is not as protected as you think it is. This week, California State Senator Tom Umberg introduced legislation to regulate the sharing of specimens collected through DNA analysis.

"What consumers don't know is the recipient of the specimen, those doing the analysis, may provide that to other entities," Umberg told Cheddar Friday. He said the new legislation will protect consumers and provide them the opportunity to make their own decisions about their data.

Illinois and New York have similar laws on the books. Illinois at the start of 2020 expanded protections for users of genetic testing kits like 23andMe and Ancestry.com

One of the concerns around the sharing of genetic testing is the disclosure of information that may have "health implications and insurance implications and maybe even employment implications," Umberg said. Tests can reveal a predisposition to a disease, information that, if sold to an entity like an insurance company, may affect the user beyond simply taking a test.

He said he became more concerned after the Department of Defense warned personnel not to use home DNA tests.

"If it's affecting national defense, I think consumers should know what's what that information is being used for," the legislator and retired U.S. Army colonel said.

The legislation Umberg introduced, California Senate Bill 980, provides for users to opt-in to letting companies pass on their information to third parties, like if the company offers some kind of compensation.

That would make it a "consumer choice," he said.

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More